| Literature DB >> 21868305 |
Jennifer F Nyland1, Myriam Fillion, Fernando Barbosa, Devon L Shirley, Chiameka Chine, Melanie Lemire, Donna Mergler, Ellen K Silbergeld.
Abstract
BACKGROUND: Mercury (Hg) is a ubiquitous environmental contaminant with neurodevelopmental and immune system effects. An informative biomarker of Hg-induced immunotoxicity could aid studies on the potential contribution to immune-related health effects.Entities:
Mesh:
Substances:
Year: 2011 PMID: 21868305 PMCID: PMC3261989 DOI: 10.1289/ehp.1103741
Source DB: PubMed Journal: Environ Health Perspect ISSN: 0091-6765 Impact factor: 9.031
Figure 1Hg and Se distribution in population. Total Hg levels (A,B) and total Se levels (C) were measured for each participant in (A,C) blood and (B) urine (creatinine-corrected values). Data are shown on the natural scale and are right-skewed as in previous studies of individuals from this study area. The predicted probability (line overlay) of high (titer > 1:80) ANA measures in serum is plotted as relates to (A) blood Hg (p = 0.031; OR = 2.6; 95% CI: 1.1, 6.2), (B) urine Hg (p = 0.70; OR = 1.2; 95% CI: 0.5, 3.1), and (C) blood Se (p = 0.57; OR = 2.5; 95% CI: 0.1, 62.8).
Associations between ANA and Hg level (OR and 95% CI for a log change in Hg exposure).
| Biomarker | Blood Hg | Plasma Hg | Hair Hg | Urine Hg | ||||
|---|---|---|---|---|---|---|---|---|
| Unadjusted associations | ||||||||
| High ANA (≥ 1:80) | 2.6 (1.1, 6.2) | 19.9 (2.4, 163.9) | 3.4 (0.6, 19.2) | 1.2 (0.5, 3.1) | ||||
| Mid-ANA (≥ 1:40) | 1.3 (0.8, 2.2) | 2.1 (0.8, 5.7) | 1.6 (0.5, 4.9) | 0.7 (0.4, 1.4) | ||||
| Adjusted associations | ||||||||
| High ANA (≥ 1:80) | 2.8 (1.1, 7.5) | 28.3 (2.9, 273.2) | 3.9 (0.6, 24.3) | 1.2 (0.5, 3.2) | ||||
| Mid-ANA (≥ 1:40) | 1.3 (0.8, 2.2) | 2.1 (0.8, 5.6) | 1.5 (0.5, 4.6) | 0.7 (0.4, 1.4) | ||||
| Values [OR (95% CI)] are reported for unadjusted and
adjusted biomarkers. | ||||||||
Figure 2ANA titer by blood Hg quartile. Serum samples from the study population (n = 232) were serially diluted and assayed for ANA. Results show the proportion of the population for each blood Hg quartile that had detectable amounts of ANA at the titer noted, with negative indicating that no ANA was detectable at any dilution. Significance of associations between elevated titers of ANA and Hg exposure was evaluated with logistic regression, using quartile of Hg exposure as a categorical variable. Positive associations between percent positive for high ANA (defined as > 1:80) and elevated Hg exposure (by quartile) were found between the first and fourth Hg quartile (OR = 3.0; 95% CI: 0.99, 9.0).
Associations between serum cytokines and Hg level [r (95% CI)].
| Cytokine | Blood Hg | Plasma Hg | Hair Hg | Urine Hg | ||||
|---|---|---|---|---|---|---|---|---|
| Unadjusted associations | ||||||||
| IL-1β | 0.2 (–0.4, 0.7) | 0.0 (–0.4, 0.4) | 0.0 (–0.5, 0.5) | 0.0 (–0.1, 0.1) | ||||
| IL-1ra | 0.0 (–0.5, 0.6) | –0.3 (–0.7, 0.1) | 0.0 (–0.5, 0.6) | 0.0 (–0.1, 0.0) | ||||
| IL-4 | 0.5 (0.0, 1.0) | 0.5 (0.1, 0.9) | 0.3 (–0.2, 0.8) | 0.0 (0.0, 0.1) | ||||
| IL-6 | 0.6 (0.0, 1.1) | 0.4 (0.0, 0.8) | 0.5 (0.0, 1.0) | 0.1 (0.0, 0.1) | ||||
| IL-10 | 0.2 (–0.2, 0.5) | –0.1 (–0.3, 0.2) | 0.1 (–0.3, 0.5) | 0.0 (0.0, 0.1) | ||||
| IL-17 | 0.2 (0.0, 0.5) | 0.2 (0.0, 0.4) | 0.2 (0.0, 0.4) | 0.0 (0.0, 0.0) | ||||
| IFN-γ | 0.8 (–0.1, 1.6) | 0.9 (0.2, 1.5) | 0.5 (–0.3, 1.3) | 0.1 (0.0, 0.2) | ||||
| TNF-α | 0.0 (–0.4, 0.4) | 0.1 (–0.2, 0.4) | –0.1 (–0.5, 0.3) | 0.0 (0.0, 0.1) | ||||
| Adjusted associations | ||||||||
| IL-1β | 0.1 (–0.5, 0.7) | –0.1 (–0.5, 0.4) | –0.1 (–0.6, 0.5) | 0.0 (–0.1, 0.1) | ||||
| IL-1ra | 0.1 (–0.5, 0.6) | –0.3 (–0.7, 0.1) | 0.1 (–0.5, 0.6) | 0.0 (–0.1, 0.1) | ||||
| IL-4 | 0.4 (–0.1, 0.9) | 0.5 (0.1, 0.9) | 0.2 (–0.3, 0.7) | 0.0 (0.0. 0.1) | ||||
| IL-6 | 0.6 (0.0, 1.2) | 0.4 (0.0, 0.9) | 0.5 (0.0, 1.1) | 0.1 (0.0, 0.1) | ||||
| IL-10 | 0.1 (–0.3, 0.5) | –0.1 (–0.4, 0.2) | 0.1 (–0.3, 0.5) | 0.0 (0.0, 0.1) | ||||
| IL-17 | 0.2 (–0.1, 0.4) | 0.2 (0.0, 0.4) | 0.1 (–0.1, 0.4) | 0.0 (0.0, 0.0) | ||||
| IFN-γ | 0.7 (–0.2, 1.6) | 0.8 (0.2, 1.5) | 0.5 (–0.4, 1.3) | 0.1 (0.0, 0.2) | ||||
| TNF-α | 0.0 (–0.4, 0.4) | 0.1 (–0.2, 0.4) | –0.2 (–0.5, 0.2) | 0.0 (0.0, 0.1) | ||||
| Values are reported for unadjusted and adjusted biomarkers.
| ||||||||
Serum cytokine measurements [pg/mL; median (interguartile range)] according to ANA status and Hg exposure.
| Group | Hg level [median (CI)] | IL-1β | IL-4 | IL-6 | IFN-γ | TNF-α | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| High Hg/ANA+ | 9 | 103.1 (79.4, 122.1) | 1.5 (1.5–2.1) | 1.3 (1.0–1.8) | 5.0 (3.5–7.2) | 70.1 (50.5–90.4) | 7.9 (6.7–15.2) | |||||||
| High Hg/ANA– | 39 | 93.6 (84.6, 101.3) | 0.7 (0.5–1.5) | 0.2 (0.2–0.2) | 1.4 (1.2–6.3) | 1.3 (1.3–1.7) | 4.6 (3.2–4.7) | |||||||
| Low Hg/ANA+ | 5 | 21.1 (16.8, 25.3) | 2.2 (1.8–2.5) | 2.2 (1.5–3.0) | 5.8 (4.0–7.6) | 71.2 (52.1–136.0) | 12.0 (7.4–20.2) | |||||||
| Low Hg/ANA– | 43 | 15.3 (13.1, 19.4) | 0.7 (0.2–1.5) | 0.2 (0.2–0.2) | 1.2 (1.2–2.6) | 1.3 (1.3–1.7) | 4.6 (4.5–4.7) | |||||||
| ANOVA | ||||||||||||||